Recombinant multi-species HMGB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HMGB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the non-histone chromosomal high mobility group protein family. The proteins of this family are chromatin-associated and ubiquitously distributed in the nucleus of higher eukaryotic cells. In vitro studies have demonstrated that this protein is able to efficiently bend DNA and form DNA circles. These studies suggest a role in facilitating cooperative interactions between cis-acting proteins by promoting DNA flexibility. This protein was also reported to be involved in the final ligation step in DNA end-joining processes of DNA double-strand breaks repair and V(D)J recombination. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HMGB2,High mobility group protein B2,High mobility group protein 2 (HMG-2),HMG2
Go
to HMGB2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T12974-Ab-1/ GM-Tg-hg-T12974-Ab-2 | Human HMGB2 protein | Human |
GM-Tg-rg-T12974-Ab-1/ GM-Tg-rg-T12974-Ab-2 | Rat HMGB2 protein | Rat |
GM-Tg-mg-T12974-Ab-1/ GM-Tg-mg-T12974-Ab-2 | Mouse HMGB2 protein | Mouse |
GM-Tg-cynog-T12974-Ab-1/ GM-Tg-cynog-T12974-Ab-2 | Cynomolgus/Rhesus macaque HMGB2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T12974-Ab-1/ GM-Tg-felg-T12974-Ab-2 | Feline HMGB2 protein | Feline |
GM-Tg-cang-T12974-Ab-1/ GM-Tg-cang-T12974-Ab-2 | Canine HMGB2 protein | Canine |
GM-Tg-bovg-T12974-Ab-1/ GM-Tg-bovg-T12974-Ab-2 | Bovine HMGB2 protein | Bovine |
GM-Tg-equg-T12974-Ab-1/ GM-Tg-equg-T12974-Ab-2 | Equine HMGB2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T12974-Ab-1/ GM-Tg-hg-T12974-Ab-2;
GM-Tg-rg-T12974-Ab-1/ GM-Tg-rg-T12974-Ab-2;
GM-Tg-mg-T12974-Ab-1/ GM-Tg-mg-T12974-Ab-2; GM-Tg-cynog-T12974-Ab-1/ GM-Tg-cynog-T12974-Ab-2; GM-Tg-felg-T12974-Ab-1/ GM-Tg-felg-T12974-Ab-2; GM-Tg-cang-T12974-Ab-1/ GM-Tg-cang-T12974-Ab-2; GM-Tg-bovg-T12974-Ab-1/ GM-Tg-bovg-T12974-Ab-2; GM-Tg-equg-T12974-Ab-1/ GM-Tg-equg-T12974-Ab-2 |
Products Name | HMGB2 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | HMGB2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HMGB2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.